Premium
New report examines medication trends for depression, anxiety and insomnia
Author(s) -
Canady Valerie A.
Publication year - 2020
Publication title -
mental health weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7583
pISSN - 1058-1103
DOI - 10.1002/mhw.32344
Subject(s) - anxiety , insomnia , depression (economics) , medical prescription , pharmacy , covid-19 , antidepressant , psychiatry , medicine , psychology , family medicine , pharmacology , disease , infectious disease (medical specialty) , economics , macroeconomics
As COVID‐19 continues to significantly impact the United States from a physical, mental and financial standpoint, an early analysis by a pharmacy benefit management organization of filled prescriptions at the onset of COVID‐19 has found increases in the use of anti‐anxiety and antidepressant medications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom